Close

Interviews

A World Pharma Today exclusive with Jim Murphy, CEO, Greenphire

Who would have thought a pandemic in this modern era would cripple the world, the strongest economies would be shaken, and end up being so vulnerable despite having the most modern technologies and processes at our disposal. That being...

A new generation of therapies are improving survival rates for liver cancer patients

Stand first: There are many alarming statistics concerning liver cancer; especially if you are an Asian man: For one, nearly 80% of all the cases in the world occur in Asia, and while it is only the fifth most common...

In conversation with Karen Reddington on Pharma Logistics Landscape in Asia

In a scenario where time is of the essence, it becomes all the more important for industries to make continuous amendments as far as their processes are concerned. These processes become all the more noteworthy and challenging in a...

Matthias Maaz from Honeywell spotlight on improved processes through Pharma 4.0 and IoT

How has your experience been at this coveted Pharma Manufacturing & Automation Convention? We are mighty impressed with this event here in Hyderabad. It is an absolute honor to be given the opportunity to speak about Honeywell and our drive...

The pharmaceutical supply chain: A digital future starts now

As TraceLink announces its Digital Network Platform aimed at transforming the global pharmaceutical supply chain to improve business performance and become more patient centric, we spoke to John Hogan, SVP, Engineering about digital supply chain strategies, the impact of...

Interview With Dr. Claus Feussner, Senior Vice President in Vetter Development Service

“Never forget, quality in drug product manufacturing comes first. Even the smallest of details can determine the long-term success for your patients.“ Dr. Claus Feussner, Senior Vice President Development Service Early planning and attention to detail can make the difference...

Overcoming the challenges in drug device combination product formulation

In conversation with Dr. Bruce Frank, V.P - Operations & Client Services, Particle Sciences on overcoming the challenges and complexities in drug device combination product formulation. 1.Regarding drug delivery related fine particles and nanotechnology formulations, how are the SATx...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »